Fernandes Liliana, Costa Raquel, Henriques Mariana, Rodrigues Maria Elisa
Centre of Biological Engineering, LMaS - Laboratório de Microbiologia Aplicada à Saúde, LABBELS -Associate Laboratory, University of Minho, Campus de Gualtar, Braga, Guimarães 4710-057, Portugal.
Costa Raquel, Aromas Aqua Spa - Clínica saúde, Praça 5 outubro n° 32, Vila Verde, Braga 4730-731, Portugal.
J Mycol Med. 2023 Mar;33(1):101329. doi: 10.1016/j.mycmed.2022.101329. Epub 2022 Sep 7.
Vulvovaginal candidiasis is a disease that affects millions of women worldwide. Oral formulations, topical creams or ointments are the conventional dosage forms, with an increase in drug administration through vaginal via. The use of simulated biological fluids (e.g. vaginal fluid) in the evaluation of antifungal therapies may better mimic the real biological environments and therefore provide a better understanding of the behavior of the antifungal.
The main objective of this work was to compare planktonic growth and biofilm formation of Candida species, on common growth medium, Sabouraud Dextrose Broth (SDB) and on vaginal simulation conditions, Simulated Vaginal Fluid (SVF), through the optical density determination, colony-forming units and scanning electron microscopy. In addition, under the same conditions this study also evaluated the ability of vapor phase of oregano and white thyme essential oils (VP-EOs), potential alternative treatment, to inhibit biofilm formation and to destroy mature biofilms of vaginal isolates, through the colony-forming units determination.
Candida isolates maintained the same biofilm formation capacity and morphology in both media (SVF and SDB). Furthermore, the results obtained in this work related with VP-EOs effect agree with results acquired, previously, with SDB. This means that the effect of VP-EOs is not affected by the SVF medium, and that this fluid allows the dissolution of the volatile and bioactive compounds.
These results can predict the in vivo behavior, suggesting a potential effective application of VP-EOs as prophylactic or therapeutic treatment for biofilm-related vulvovaginal candidiasis.
外阴阴道念珠菌病是一种影响全球数百万女性的疾病。口服制剂、外用乳膏或软膏是传统剂型,经阴道给药的方式有所增加。在抗真菌治疗评估中使用模拟生物流体(如阴道液)可能更好地模拟真实生物环境,从而更深入了解抗真菌药物的行为。
本研究的主要目的是通过测定光密度、菌落形成单位和扫描电子显微镜,比较念珠菌属在普通生长培养基沙氏葡萄糖肉汤(SDB)和阴道模拟条件模拟阴道液(SVF)中的浮游生长和生物膜形成情况。此外,在相同条件下,本研究还通过测定菌落形成单位,评估牛至和白百里香精油的气相(VP-EOs)作为潜在替代治疗方法抑制生物膜形成和破坏阴道分离株成熟生物膜的能力。
念珠菌分离株在两种培养基(SVF和SDB)中保持相同的生物膜形成能力和形态。此外,本研究中获得的与VP-EOs作用相关的结果与之前在SDB中获得的结果一致。这意味着VP-EOs的作用不受SVF培养基的影响,并且这种液体能够使挥发性和生物活性化合物溶解。
这些结果可以预测体内行为,表明VP-EOs作为与生物膜相关的外阴阴道念珠菌病的预防性或治疗性治疗方法具有潜在的有效应用前景。